Nine early-stage South Korean startups pitched at the DETO 2026 technology conference in Seoul to secure a spot in TechCrunch’s Disrupt 2027 Startup Battlefield 200 competition. The participating companies span sectors including healthcare, fintech, energy, semiconductors, and AI, with all nine targeting entry into the U.S. market as part of international expansion plans.
Voinosis, founded by former otologic surgeon Grace Shin, won the event. The startup develops an AI tool that analyzes speech patterns—including pitch, pauses, rhythm, and response times—in under five minutes to detect changes linked to brain health. The technology has been tested across Greek, Japanese, and English without requiring language-specific training. The company claimed 88% accuracy in a 146-participant clinical study and is currently raising a Series A round with backing from a South Korean pharmaceutical strategic investor.
Other competing startups included Awesome Lab, which makes a water electrolysis heating system; Crosshub, an identity and payments platform using zero-knowledge proofs; DeepFusion AI, a 4D radar imaging developer; and EFLOW, a specialized motor and actuator manufacturer for robotics.
Why it matters
Voinosis demonstrates cross-lingual voice AI applications in healthcare, achieving reported 88% screening accuracy without language-specific retrain models.
Early-stage Asian deep-tech startups are increasingly positioning US market entry as a core objective alongside initial product validation.
Investors can watch emerging startups across Korean deep tech sectors, including robotics motors, sub-surface radar imaging, and decentralized identity.
Source: techcrunch.com



